Cbsnews
6 months agoHealth
Merck-Moderna vaccine cuts odds of skin cancer recurrence in half, study finds
A vaccine developed by Moderna and Merck shows promising results in treating the most deadly form of skin cancer.
Those who received the vaccine and Merck's cancer drug Keytruda were 49% less likely to die or have their cancer come back after three years. [ more ]